1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 United States Plasma Fractionation Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 United States Plasma Fractionation Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 United States Plasma Fractionation Market - Breakup by Product
6.1 Immunoglobulins
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Forecast (2024-2032)
6.2 Albumin
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Forecast (2024-2032)
6.3 Coagulation factor VIII
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2018-2023)
6.3.3 Market Forecast (2024-2032)
6.4 Coagulation factor IX
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2018-2023)
6.4.3 Market Forecast (2024-2032)
7 United States Plasma Fractionation Market - Breakup by Sector
7.1 Private Sector
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Forecast (2024-2032)
7.2 Public Sector
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Forecast (2024-2032)
8 United States Plasma Fractionation Market - Breakup by Application
8.1 Neurology
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Forecast (2024-2032)
8.2 Immunology
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Forecast (2024-2032)
8.3 Hematology
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2018-2023)
8.3.3 Market Forecast (2024-2032)
8.4 Others
8.4.1 Historical and Current Market Trends (2018-2023)
8.4.2 Market Forecast (2024-2032)
9 United States Plasma Fractionation Market - Breakup by End User
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2018-2023)
9.1.3 Market Forecast (2024-2032)
9.2 Clinical Research Laboratories
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2018-2023)
9.2.3 Market Forecast (2024-2032)
9.3 Academic Institutes
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2018-2023)
9.3.3 Market Forecast (2024-2032)
10 United States Plasma Fractionation Market – Breakup by Region
10.1 Northeast
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2018-2023)
10.1.3 Market Breakup by Product
10.1.4 Market Breakup by Sector
10.1.5 Market Breakup by Application
10.1.6 Market Breakup by End User
10.1.7 Key Players
10.1.8 Market Forecast (2024-2032)
10.2 Midwest
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2018-2023)
10.2.3 Market Breakup by Product
10.2.4 Market Breakup by Sector
10.2.5 Market Breakup by Application
10.2.6 Market Breakup by End User
10.2.7 Key Players
10.2.8 Market Forecast (2024-2032)
10.3 South
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2018-2023)
10.3.3 Market Breakup by Product
10.3.4 Market Breakup by Sector
10.3.5 Market Breakup by Application
10.3.6 Market Breakup by End User
10.3.7 Key Players
10.3.8 Market Forecast (2024-2032)
10.4 West
10.4.1 Overview
10.4.2 Historical and Current Market Trends (2018-2023)
10.4.3 Market Breakup by Product
10.4.4 Market Breakup by Sector
10.4.5 Market Breakup by Application
10.4.6 Market Breakup by End User
10.4.7 Key Players
10.4.8 Market Forecast (2024-2032)
11 United States Plasma Fractionation Market – Competitive Landscape
11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant
12 Profiles of Key Players
12.1 Company A
12.1.1 Business Overview
12.1.2 Product Portfolio
12.1.3 Business Strategies
12.1.4 SWOT Analysis
12.1.5 Major News and Events
12.2 Company B
12.2.1 Business Overview
12.2.2 Product Portfolio
12.2.3 Business Strategies
12.2.4 SWOT Analysis
12.2.5 Major News and Events
12.3 Company C
12.3.1 Business Overview
12.3.2 Product Portfolio
12.3.3 Business Strategies
12.3.4 SWOT Analysis
12.3.5 Major News and Events
12.4 Company D
12.4.1 Business Overview
12.4.2 Product Portfolio
12.4.3 Business Strategies
12.4.4 SWOT Analysis
12.4.5 Major News and Events
12.5 Company E
12.5.1 Business Overview
12.5.2 Product Portfolio
12.5.3 Business Strategies
12.5.4 SWOT Analysis
12.5.5 Major News and Events
Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.
13 United States Plasma Fractionation Market - Industry Analysis
13.1 Drivers, Restraints, and Opportunities
13.1.1 Overview
13.1.2 Drivers
13.1.3 Restraints
13.1.4 Opportunities
13.2 Porters Five Forces Analysis
13.2.1 Overview
13.2.2 Bargaining Power of Buyers
13.2.3 Bargaining Power of Suppliers
13.2.4 Degree of Competition
13.2.5 Threat of New Entrants
13.2.6 Threat of Substitutes
13.3 Value Chain Analysis
14 Appendix